Delivery Order SPE2DB22D9207-SPE2DB25FH5AD
Award Date
5/13/25
Potential Completion Date
6/4/25
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The $11,840.00 firm fixed-price contract has a period of performance through May 31, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,104.00 firm fixed-price delivery order is for the supply of MIRENA 52 MG SYSTEMS, a specialized contraceptive product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $7,104.00 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of Mirena 52 mg systems, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of Mirena 52 mg Systems to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,776.00 firm fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of the MIRENA 52 MG SYSTEMS pharmaceutical product. The $6,249.24 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of April 9, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $13,019.25 contract is for the delivery of MIRENA 52 MG SYSTEMS, a contraceptive device, with a performance period ending on June 4, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders...
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $3,552.00 contract is to provide the Mirena 52 mg systems, a contraceptive device, with an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a delivery order valued at $10,415.40 for the supply of Mirena 52 mg systems, a contraceptive device. The contract is a firm fixed-price arrangement with an ultimate completion date of April 25, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $17,760.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through October 2, 2024, is for the delivery of Mirena 52 mg systems, a branded contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,104.00 order is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive product, with a period of performance through October 15, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...